The availability of effective antiretroviral therapy has lowered the risk, and the severity, of neural sequelae of HIV infection. “Early in the HIV pandemic, approximately 15% of people with HIV had ...
An open letter to US Secretary of State Marco Rubio signed by hundreds of high-profile HIV doctors, researchers and public ...
Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
9h
AllAfrica on MSNJournalists Trained in Ethical Reporting to Boost HIV/Aids AwarenessAccurate and ethical journalism on HIV/AIDS plays a vital role in shaping public perceptions, encouraging behavioral change, and raising awareness. Misinformation or vague reporting, however, can ...
23h
LGBTQ Nation on MSNOnce-a-year shot for HIV protection passes early safety trialAn annual shot to protect against HIV infection has successfully passed an early safety trial, according to research ...
During the opening day of the Conference on Retroviruses and Opportunistic Infections, Rebecca Denison, a decades-long HIV ...
AIDS advocates are fearful that budget cuts being pushed by Republicans will gut essential health care services in the United ...
PEPFAR, a global program to combat AIDS, faces an existential threat due to partisan politics, but Congress has an opportunity to reform the program and ensure its continued success.
The advent of effective antiretroviral therapy (ART) has increased the lifespan of many people living with HIV. As a result, ...
UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...
Prevalence varies by region and is impacted by social stigma, access to preventive medicine and a lack of HIV/AIDS education, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results